Imaging of Cancer Immunotherapy: Response Assessment Methods, Atypical Response Patterns, and Immune-Related Adverse Events, From the <i>AJR</i> Special Series on Imaging of Inflammation.

Sheikhbahaei, Sara; Marcus, Charles V; Sadaghiani, Mohammad S; Rowe, Steven P; Pomper, Martin G; Solnes, Lilja B

Imaging of Cancer Immunotherapy: Response Assessment Methods, Atypical Response Patterns, and Immune-Related Adverse Events, From the AJR Special Series on Imaging of Inflammation.

Sheikhbahaei, Sara; Marcus, Charles V; Sadaghiani, Mohammad S; Rowe, Steven P; Pomper, Martin G; Solnes, Lilja B.

Afiliación

Sheikhbahaei S; The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, 601 N Caroline St, Johns Hopkins Outpatient Center, JHOC #3009, Baltimore, MD 21287.
Marcus CV; Department of Radiology, Emory University, Atlanta, GA.
Sadaghiani MS; The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, 601 N Caroline St, Johns Hopkins Outpatient Center, JHOC #3009, Baltimore, MD 21287.
Rowe SP; The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, 601 N Caroline St, Johns Hopkins Outpatient Center, JHOC #3009, Baltimore, MD 21287.
Pomper MG; The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, 601 N Caroline St, Johns Hopkins Outpatient Center, JHOC #3009, Baltimore, MD 21287.
Solnes LB; The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, 601 N Caroline St, Johns Hopkins Outpatient Center, JHOC #3009, Baltimore, MD 21287.

AJR Am J Roentgenol ; 218(6): 940-952, 2022 06.

Article en En | MEDLINE | ID: mdl-34612682

Asunto(s)

Inmunoterapia; Neoplasias; Humanos; Inhibidores de Puntos de Control Inmunológico; Inmunoterapia/efectos adversos; Inflamación; Neoplasias/diagnóstico por imagen; Neoplasias/tratamiento farmacológico; Criterios de Evaluación de Respuesta en Tumores Sólidos

Palabras clave

adverse event; immune-checkpoint inhibitors; immunotherapy; pseudoprogression; response

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inmunoterapia / Neoplasias Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: AJR Am J Roentgenol Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google